Dug Evidence Destruction Services RFI.pdf

FEDERAL BUREAU OF INVESTIGATION

FINANCE AND FACILITIES DIVISION | PROCUREMENT SECTION

REQUEST FOR INFORMATION

Drug Evidence Destruction Services (Non-Retrievable Disposal Methods)

NAICS: 562211 – Hazardous Waste Treatment and Disposal

PSC: F999 – Other Environmental Services

1. Purpose

This Request for Information (RFI) is issued to identify qualified vendors capable of providing safe, compliant, and environmentally responsible destruction of drugs and related evidence. This RFI supports market research to inform potential future contracting actions. For purposes of this RFI, “controlled substances” includes illicit drugs and legally possessed pharmaceuticals.

2. Background

Federal agencies are experiencing a significant increase in the volume of seized drugs requiring destruction. Traditional incineration capacity - particularly on the West Coast - has declined, creating operational, safety, and logistical challenges.

Current policy emphasizes destruction methods that render drugs "non-retrievable" in accordance with applicable federal regulations (e.g., 21 CFR 1317.05).

The Government is exploring alternative destruction methods beyond traditional incineration that meet regulatory, safety, and environmental standards.

The Government is specifically seeking solutions that reduce transportation distances, minimize personnel requirements for escorted and witnessed destruction, and mitigate safety, environmental, and cost risks associated with limited destruction infrastructure, particularly on the West Coast.

3. Scope of Interest

The Government seeks information on vendor capabilities to provide end-to-end drug destruction services, including but not limited to:

• Transportation (if applicable)

• Secure handling and chain of custody

• Witnessed destruction processes

• Documentation and certification of destruction

• Environmentally compliant disposal methods

4. Potential Disposal Methods of Interest

Vendors are encouraged to provide information on one or more of the following methods:

• Incineration (fixed or mobile)

• Pyrolysis

• Chemical digestion or adsorption

• Chemical encapsulation/solidification

• Alkaline hydrolysis

• Other innovative non-retrievable destruction technologies

At a minimum, all proposed destruction methods and processes must comply with 21 CFR

1317.05 and meet the definition of non-retrievable destruction.

All methods must:

• Permanently alter the drug

• Be irreversible

• Prevent future retrieval or reuse

5. Desired Outcomes

• Reduce need for long-distance transport

• Minimize personnel required for escort and witnessing

• Ensure full compliance with 21 CFR 1317.05

• Provide scalable solutions for high-volume seizures

• Maintain safety for personnel, public, and environment

6. Vendor Capability Information Requested

Interested vendors should provide the following:

6.1 Company Information

• Company name, address, and points of contact

• Business size and socio-economic status

• Relevant certifications and licenses

6.2 Technical Capability

• Description of destruction methods

• Throughput capacity (e.g., lbs/day or tons/month)

• Types of drugs supported (powder, pills, liquids, paraphernalia)

• Ability to handle bulk quantities

• Capability to safely and legally handle and destroy all categories of drugs, including both legally possessed pharmaceuticals and illicit drugs, in compliance with all applicable federal, state, and local regulations

6.3 Compliance and Safety

• Compliance with federal, state, and local regulations

• Environmental controls and emissions data

• Occupational safety protocols

6.4 Operational Capability

• Geographic coverage (especially West Coast)

• Mobile vs. fixed-site solutions

• Ability to support witnessed destruction requirements

• Typical turnaround times

6.5 Security and Chain of Custody

• Procedures for maintaining evidence integrity

• Documentation and tracking systems

6.6 Past Performance

• Relevant experience with federal, state, or local agencies

• Examples of similar projects

6.7 Pricing (Optional)

• Rough order of magnitude (ROM) pricing

• Pricing model (per pound, per event, etc.)

6.8 Feedback on Draft Performance Work Statement (PWS)

The Government is seeking industry feedback on the draft Performance Work Statement (PWS) associated with this requirement.

Respondents are encouraged to provide:

• Comments on the feasibility of requirements

• Identification of overly restrictive or unclear provisions

• Recommendations for improving performance-based outcomes

• Suggestions for innovative approaches or alternative solutions

• Feedback on industry standards and best practices

Vendors should clearly identify any assumptions, risks, or constraints associated with the draft PWS requirements.

7. Constraints and Considerations

Vendors shall describe how their proposed solutions address or mitigate the following constraints:

• Destruction may require multiple witnesses and law enforcement presence

• Facilities must meet strict security and ventilation requirements

• Transportation and storage risks must be minimized

8. Submission Instructions

Responses should be no more than 10–15 pages and submitted electronically in PDF or Word format.

Include "RFI Response – Drug Evidence Destruction" in the subject line.

Vendors are encouraged to organize responses in accordance with Section 6 of this RFI.

9. Questions

Vendors may submit questions to the Contracting Officer, Melissa Golicz, at email mgolicz@fbi.gov. All questions must be submitted in writing. No phone calls will be accepted.

10. Anticipated Acquisition Strategy

The Government is considering the use of an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle to support this requirement. The anticipated total contract capacity is estimated to be between $5 million.

The Government is evaluating both single-award and multiple-award IDIQ approaches.

This information is provided for planning purposes only and is subject to change based on the results of market research.

11. Disclaimer

This RFI is for informational and planning purposes only and does not constitute a solicitation.

The Government will not reimburse any costs associated with responding to this RFI.

End of RFI mailto:mgolicz@fbi.gov